Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Current Signal: SELL (auto-tracking)
1.22% $47.98
America/New_York / 28 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 2 780.95 mill |
EPS: | -0.0300 |
P/E: | -1 599.33 |
Earnings Date: | Apr 30, 2024 |
SharesOutstanding: | 57.96 mill |
Avg Daily Volume: | 1.004 mill |
RATING 2024-03-28 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Neutral | |
Return On Asset: | Buy | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -1 599.33 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-7.20x |
Company: PE -1 599.33 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
$-40.91 (-185.27%) $-88.89 |
Date: 2024-03-29 |
Expected Trading Range (DAY) |
---|
$ 45.46 - 50.51 ( +/- 5.26%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Hoffman William | Sell | 27 492 | Common Stock |
2024-03-18 | Hoffman William | Sell | 12 508 | Common Stock |
2024-03-12 | Hill, Mitch C. | Buy | 6 000 | Common Stock |
2024-03-12 | Hill, Mitch C. | Sell | 5 999 | Common Stock |
2024-03-12 | Hill, Mitch C. | Sell | 1 | Common Stock |
INSIDER POWER |
---|
-28.56 |
Last 100 transactions |
Buy: 339 157 | Sell: 645 748 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $47.98 (1.22% ) |
Volume | 6.48 mill |
Avg. Vol. | 1.004 mill |
% of Avg. Vol | 644.99 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $57.07 | N/A | Active |
---|
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.